NMR-Based Method Developed to Detect Nitrosamine Impurities in Pharmaceutical Ingredients

A new Nuclear Magnetic Resonance (NMR)-based method has been developed to detect nitrosamine impurities in Active Pharmaceutical Ingredients (APIs), according to recent research. This approach aims to address the limitations of traditional mass spectrometry techniques, which are commonly used for impurity detection in pharmaceutical manufacturing. Nitrosamines, classified as probable human carcinogens, have raised significant safety concerns in the pharmaceutical industry, prompting efforts to improve detection methods.

The NMR-based technique offers an alternative by providing a more targeted and potentially reliable way to identify nitrosamine contaminants during API production. Researchers suggest that this method could enhance the safety of pharmaceutical products by improving impurity monitoring processes. Traditional mass-based techniques often face challenges such as sensitivity issues and interference from complex sample matrices, which can hinder accurate detection. The development of this novel approach may help overcome these obstacles and contribute to safer manufacturing practices within the pharmaceutical sector.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

Related posts:

Drug Patent Watch: Digital Tools Help Generic Drug Developers Accelerate Timelines and Reduce Costs Investigational Drug Lorundrostat Reduces Blood Pressure and Kidney Damage Marker in CKD Patients with Hypertension Retrospective Study Finds Pulmonary Fibrosis in Patients with Severe COVID-19 Study in Nature Details Molecular Mechanisms of Florigen Activation Complex Driving Flowering in Arabidopsis

Author

GOAI